EPO 10000 IU | 10-Vial Kit — Recombinant human erythropoietin (rhEPO) — glycoprotein cytokine activating EPOR on erythroid progenitors to stimulate red blood cell production, haemoglobin synthesis, and oxygen-carrying capacity. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
EPO 10000 IU | 20-Vial Kit — Recombinant human erythropoietin (rhEPO) — glycoprotein cytokine activating EPOR on erythroid progenitors to stimulate red blood cell production, haemoglobin synthesis, and oxygen-carrying capacity. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
EPO 3000 IU | 10-Vial Kit — Recombinant human erythropoietin (rhEPO) — glycoprotein cytokine activating EPOR on erythroid progenitors to stimulate red blood cell production, haemoglobin synthesis, and oxygen-carrying capacity. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
EPO 3000 IU | 20-Vial Kit — Recombinant human erythropoietin (rhEPO) — glycoprotein cytokine activating EPOR on erythroid progenitors to stimulate red blood cell production, haemoglobin synthesis, and oxygen-carrying capacity. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
GDF-8 (Myostatin) 1mg | 10-Vial Kit — recombinant human myostatin, endogenous TGF-β superfamily member that limits skeletal muscle mass; used as research reference to characterise myostatin inhibition models and validate FST-344/ACE-031 effects. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
GDF-8 (Myostatin) 1mg | 20-Vial Kit — recombinant human myostatin, endogenous TGF-β superfamily member that limits skeletal muscle mass; used as research reference to characterise myostatin inhibition models and validate FST-344/ACE-031 effects. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.